Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf Marco RuellaSaad S. Kenderian Current Opinion 16 November 2017 Pages: 473 - 481
The Application of CGRP(r) Monoclonal Antibodies in Migraine Spectrum: Needs and Priorities Paolo Martelletti Commentary 09 November 2017 Pages: 483 - 485
CGRP Monoclonal Antibodies for Migraine: Rationale and Progress Hsiangkuo YuanClinton G. LauritsenStephen D. Silberstein Review Article 07 November 2017 Pages: 487 - 501
Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology William M. Pardridge Review Article 24 October 2017 Pages: 503 - 519
Recent Developments in ADC Technology: Preclinical Studies Signal Future Clinical Trends Penelope M. DrakeDavid Rabuka Review Article Open access 08 November 2017 Pages: 521 - 531
Impact of Infliximab and Etanercept Biosimilars on Biological Disease-Modifying Antirheumatic Drugs Utilisation and NHS Budget in the UK Mohammed I. AladulRaymond W. FitzpatrickStephen R. Chapman Original Research Article 10 November 2017 Pages: 533 - 544
Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants Elisa V. GomezJessie L. BishopDiane Phillips Original Research Article Open access 07 November 2017 Pages: 545 - 554
GP2015: An Etanercept Biosimilar Emma D. Deeks Adis Biosimilar Brief Open access 23 September 2017 Pages: 555 - 558